These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 35710250)
1. Optimising Xpert-Ultra and culture testing to reliably measure tuberculosis prevalence in the community: findings from surveys in Zambia and South Africa. Floyd S; Klinkenberg E; de Haas P; Kosloff B; Gachie T; Dodd PJ; Ruperez M; Wapamesa C; Burnett MJ; Kalisvaart N; Vermaak R; Mainga T; Schaap A; Fidler S; Mureithi L; Shanaube K; Hayes R; Ayles H; BMJ Open; 2022 Jun; 12(6):e058195. PubMed ID: 35710250 [TBL] [Abstract][Full Text] [Related]
2. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS). Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H; PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971 [TBL] [Abstract][Full Text] [Related]
3. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study. Mishra H; Reeve BWP; Palmer Z; Caldwell J; Dolby T; Naidoo CC; Jackson JG; Schumacher SG; Denkinger CM; Diacon AH; van Helden PD; Marx FM; Warren RM; Theron G Lancet Respir Med; 2020 Apr; 8(4):368-382. PubMed ID: 32066534 [TBL] [Abstract][Full Text] [Related]
4. Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa. Ruperez M; Shanaube K; Mureithi L; Wapamesa C; Burnett MJ; Kosloff B; de Haas P; Hayes R; Fidler S; Gachie T; Schaap A; Floyd S; Klinkenberg E; Ayles H; Lancet Glob Health; 2023 May; 11(5):e704-e714. PubMed ID: 37061309 [TBL] [Abstract][Full Text] [Related]
5. Evidence for Tuberculosis in Individuals With Xpert Ultra "Trace" Sputum During Screening of High-Burden Communities. Sung J; Nantale M; Nalutaaya A; Biché P; Mukiibi J; Kamoga CE; Akampurira J; Kayondo F; Kiyonga R; Mukiibi M; Nakasolya O; McGeehan M; Dowdy DW; Katamba A; Kendall EA Clin Infect Dis; 2024 Mar; 78(3):723-729. PubMed ID: 37787077 [TBL] [Abstract][Full Text] [Related]
7. The New Xpert MTB/RIF Ultra: Improving Detection of Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D mBio; 2017 Aug; 8(4):. PubMed ID: 28851844 [TBL] [Abstract][Full Text] [Related]
8. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis. Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert MTB/RIF Ultra and Molbio Truenat MTB Ultima. Wood RC; Luabeya AK; Dragovich RB; Olson AM; Lochner KA; Weigel KM; Codsi R; Mulenga H; de Vos M; Kohli M; Penn-Nicholson A; Hatherill M; Cangelosi GA J Clin Microbiol; 2024 Apr; 62(4):e0001924. PubMed ID: 38483169 [TBL] [Abstract][Full Text] [Related]
10. The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda. Andama A; Jaganath D; Crowder R; Asege L; Nakaye M; Katumba D; Mukwatamundu J; Mwebe S; Semitala CF; Worodria W; Joloba M; Mohanty S; Somoskovi A; Cattamanchi A BMC Infect Dis; 2021 Jan; 21(1):49. PubMed ID: 33430790 [TBL] [Abstract][Full Text] [Related]
11. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study. Turner CT; Gupta RK; Tsaliki E; Roe JK; Mondal P; Nyawo GR; Palmer Z; Miller RF; Reeve BW; Theron G; Noursadeghi M Lancet Respir Med; 2020 Apr; 8(4):407-419. PubMed ID: 32178775 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495 [TBL] [Abstract][Full Text] [Related]
13. Policy and programmatic directions for the Lesotho tuberculosis programme: Findings of the national tuberculosis prevalence survey, 2019. Matji R; Maama L; Roscigno G; Lerotholi M; Agonafir M; Sekibira R; Law I; Tadolini M; Kak N PLoS One; 2023; 18(3):e0273245. PubMed ID: 36893175 [TBL] [Abstract][Full Text] [Related]
14. Retrospective Diagnostic Accuracy Study of Abbott RealTi Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811 [TBL] [Abstract][Full Text] [Related]
15. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study. Kendall EA; Schumacher SG; Denkinger CM; Dowdy DW PLoS Med; 2017 Dec; 14(12):e1002472. PubMed ID: 29240766 [TBL] [Abstract][Full Text] [Related]
16. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa. Lawn SD; Kerkhoff AD; Burton R; Schutz C; van Wyk G; Vogt M; Pahlana P; Nicol MP; Meintjes G BMC Med; 2015 Aug; 13():192. PubMed ID: 26275908 [TBL] [Abstract][Full Text] [Related]
17. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting. Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896 [TBL] [Abstract][Full Text] [Related]
18. Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa. Berhanu RH; Lebina L; Nonyane BAS; Milovanovic M; Kinghorn A; Connell L; Nyathi S; Young K; Hausler H; Naidoo P; Brey Z; Shearer K; Genade L; Martinson NA Clin Infect Dis; 2023 May; 76(9):1594-1603. PubMed ID: 36610730 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre. Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567 [TBL] [Abstract][Full Text] [Related]
20. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial. Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]